{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:06:03Z","timestamp":1776121563290,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:00:00Z","timestamp":1392163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:00:00Z","timestamp":1392163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep04076","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T10:03:13Z","timestamp":1392199393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ureaplasma, bronchopulmonary dysplasia and azithromycin in European neonatal intensive care units: a survey"],"prefix":"10.1038","volume":"4","author":[{"given":"Claudia","family":"Pansieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pandolfini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery","family":"Elie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailesh","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Jacqz-Aigrain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Bonati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,12]]},"reference":[{"key":"BFsrep04076_CR1","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMra067279","volume":"357","author":"E Baraldi","year":"2007","unstructured":"Baraldi, E. & Filippone, M. Chronic lung disease after premature birth. N. Engl. J. Med. 357, 1946\u20131955 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep04076_CR2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1542\/peds.2004-0204","volume":"114","author":"MC Walsh","year":"2004","unstructured":"Walsh, M. C. et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 114, 1305\u20131311(2004).","journal-title":"Pediatrics."},{"key":"BFsrep04076_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1586\/17476348.1.2.247","volume":"1","author":"A Lall","year":"2007","unstructured":"Lall, A., Prendergast, M. & Greenough, A. Risk factors for the development of bronchopulmonary dysplasia: the role of antenatal infection and inflammation. Expert Rev. Respir. Med. 1, 247\u2013254 (2007).","journal-title":"Expert Rev. Respir. Med."},{"key":"BFsrep04076_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.siny.2009.07.013","volume":"14","author":"AG Philip","year":"2009","unstructured":"Philip, A. G. Chronic lung disease of prematurity: a short history. Semin. Fetal Neonatal Med. 14, 333\u2013338 (2009).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"BFsrep04076_CR5","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1542\/peds.2008-0656","volume":"123","author":"MM Lahra","year":"2009","unstructured":"Lahra, M. M., Beeby, P. J. & Jeffery, H. E. Intrauterine inflammation, neonatal sepsis and chronic lung disease: a 13-year hospital cohort study. Pediatrics. 123, 1314\u20131319 (2009).","journal-title":"Pediatrics."},{"key":"BFsrep04076_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1203\/00006450-200211000-00017","volume":"52","author":"RW Redline","year":"2002","unstructured":"Redline, R. W., Wilson-Costello, D. & Hack, M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr. Res. 52, 713\u2013719 (2002).","journal-title":"Pediatr. Res."},{"key":"BFsrep04076_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.semperi.2006.05.005","volume":"30","author":"V Bhandari","year":"2006","unstructured":"Bhandari, V. & Gruen, J. R. The genetics of bronchopulmonary dysplasia. Semin. Perinatol. 30, 185\u2013191 (2006).","journal-title":"Semin. Perinatol."},{"key":"BFsrep04076_CR8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.201103-0548OC","volume":"184","author":"A Hadchouel","year":"2011","unstructured":"Hadchouel, A. et al. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 184, 1164\u20131170 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFsrep04076_CR9","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1183\/09031936.00037810","volume":"37","author":"ML Beeton","year":"2011","unstructured":"Beeton, M. L. et al. Role of pulmonary infection in the development of chronic lung disease of prematurity. Eur. Respir. J. 37, 1424\u20131430 (2011).","journal-title":"Eur. Respir. J."},{"key":"BFsrep04076_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(88)92536-6","volume":"2","author":"GH Cassell","year":"1988","unstructured":"Cassell, G. H. et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet. 2, 240\u2013245 (1988).","journal-title":"Lancet."},{"key":"BFsrep04076_CR11","doi-asserted-by":"publisher","first-page":"84R","DOI":"10.1203\/PDR.0b013e31819dc2f9","volume":"65","author":"RM Viscardi","year":"2009","unstructured":"Viscardi, R. M. & Hasday, J. D. Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence. Pediatr. Res. 65, 84R\u201390R (2009).","journal-title":"Pediatr. Res."},{"key":"BFsrep04076_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/CMR.18.4.757-789.2005","volume":"18","author":"KB Waites","year":"2005","unstructured":"Waites, K. B., Katz, B. & Schelonka, R. L. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin. Microbiol. Rev. 18, 757\u2013789 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFsrep04076_CR13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/jcm.35.5.1199-1202.1997","volume":"35","author":"M Abele-Horn","year":"1997","unstructured":"Abele-Horn, M., Wolff, C., Dressel, P., Pfaff, F. & Zimmermann, A. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients and gynecological patients with pelvic inflammatory disease. J. Clin. Microbiol. 35, 1199\u20131202 (1997).","journal-title":"J. Clin. Microbiol."},{"key":"BFsrep04076_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/rr35","volume":"2","author":"AH Jobe","year":"2001","unstructured":"Jobe, A. H. & Ikegami, M. Antenatal infection\/inflammation and postnatal lung maturation and injury. Respir. Res. 2, 27\u201332 (2001).","journal-title":"Respir. Res."},{"key":"BFsrep04076_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/adc.2010.195180","volume":"97","author":"MA Turner","year":"2012","unstructured":"Turner, M. A., Jacqz-Aigrain, E. & Kotecha, S. Azithromycin, Ureaplasma and chronic lung disease of prematurity: a case study for neonatal drug development. Arch. Dis. Child. 97, 573\u2013577 (2012).","journal-title":"Arch. Dis. Child."},{"key":"BFsrep04076_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000313024","volume":"99","author":"L Gortner","year":"2011","unstructured":"Gortner, L. et al. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort. Neonatology. 99, 112\u2013117 (2011).","journal-title":"Neonatology."},{"key":"BFsrep04076_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1128\/CMR.6.1.69","volume":"6","author":"GH Cassell","year":"1993","unstructured":"Cassell, G. H., Waites, K. B., Watson, H. L., Crouse, D. T. & Harasawa, R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin. Microbiol. Rev. 6, 69\u201387 (1993).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFsrep04076_CR18","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1093\/clinids\/17.Supplement_1.S107","volume":"17","author":"PJ Sanchez","year":"1993","unstructured":"Sanchez, P. J. Perinatal transmission of Ureaplasma urealyticum: current concepts based on review of the literature. Clin. Infect. Dis. 17 Suppl 1 S107\u2013S111 (1993).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep04076_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ppul.21352","volume":"46","author":"HO Ballard","year":"2011","unstructured":"Ballard, H. O. et al. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial. Pediatr. Pulmonol. 46, 111\u2013118 (2011).","journal-title":"Pediatr. Pulmonol."},{"key":"BFsrep04076_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.earlhumdev.2008.12.002","volume":"85","author":"NC Maxwell","year":"2009","unstructured":"Maxwell, N. C., Nuttall, D. & Kotecha, S. Does Ureaplasma spp. cause chronic lung disease of prematurity: ask the audience? Early Hum. Dev. 85, 291\u2013296 (2009).","journal-title":"Early Hum. Dev."},{"key":"BFsrep04076_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1203\/PDR.0b013e3181d026c3","volume":"67","author":"MS Payne","year":"2010","unstructured":"Payne, M. S. et al. Molecular microbiological characterization of preterm neonates at risk of bronchopulmonary dysplasia. Pediatr. Res. 67, 412\u2013418 (2010).","journal-title":"Pediatr. Res."},{"key":"BFsrep04076_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1203\/01.PDR.0000155944.48195.97","volume":"57","author":"R Miralles","year":"2005","unstructured":"Miralles, R. et al. Relationship between antenatal inflammation and antenatal infection identified by detection of microbial genes by polymerase chain reaction. Pediatr. Res. 57, 570\u2013577 (2005).","journal-title":"Pediatr. Res."},{"key":"BFsrep04076_CR23","doi-asserted-by":"publisher","first-page":"F90","DOI":"10.1136\/fn.72.2.F90","volume":"72","author":"S Kotecha","year":"1995","unstructured":"Kotecha, S., Chan, B., Azam, N., Silverman, M. & Shaw, R. J. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch. Dis. Child. Fetal Neonatal Ed. 72, F90\u2013F96 (1995).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"BFsrep04076_CR24","doi-asserted-by":"publisher","first-page":"e1496","DOI":"10.1542\/peds.2011-1350","volume":"128","author":"R Ozdemir","year":"2011","unstructured":"Ozdemir, R. et al. Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants. Pediatrics. 128, e1496\u2013e1501 (2011).","journal-title":"Pediatrics."},{"key":"BFsrep04076_CR25","doi-asserted-by":"publisher","first-page":"F10","DOI":"10.1136\/fn.78.1.F10","volume":"78","author":"AJ Lyon","year":"1998","unstructured":"Lyon, A. J. et al. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 78, F10\u2013F14 (1998).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"BFsrep04076_CR26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1651-2227.1998.tb01418.x","volume":"87","author":"B Jonsson","year":"1998","unstructured":"Jonsson, B., Rylander, M. & Faxelius, G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr. 87, 1079\u20131084 (1998).","journal-title":"Acta Paediatr."},{"key":"BFsrep04076_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2431-3-10","volume":"3","author":"RJ Baier","year":"2003","unstructured":"Baier, R. J., Loggins, J. & Kruger, T. E. Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants. BMC Pediatr. 3, 10 (2003).","journal-title":"BMC Pediatr."},{"key":"BFsrep04076_CR28","first-page":"1070","volume":"42","author":"MM Gharehbaghi","year":"2012","unstructured":"Gharehbaghi, M. M., Peirovifar, A., Ghojazadeh, M. & Mahallei, M. Efficacy of azithromycin for prevention of bronchopulmonary dysplasia (BPD). Turk J. Med. Sci. 42, 1070\u20131075 (2012).","journal-title":"Turk J. Med. Sci."},{"key":"BFsrep04076_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1179\/joc.2011.23.2.77","volume":"23","author":"Z Samra","year":"2011","unstructured":"Samra, Z., Rosenberg, S. & Dan, M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J. Chemother. 23, 77\u20139 (2011).","journal-title":"J. Chemother."},{"key":"BFsrep04076_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1203\/PDR.0b013e3181aabd34","volume":"66","author":"SA Walls","year":"2009","unstructured":"Walls, S. A. et al. Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice. Pediatr. Res. 66, 197\u2013202 (2009).","journal-title":"Pediatr. Res."},{"key":"BFsrep04076_CR31","doi-asserted-by":"crossref","unstructured":"Mabanta, C. G., Pryhuber, G. S., Weinberg, G. A. & Phelps, D. L. Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst. Rev. CD003744 (2003).","DOI":"10.1002\/14651858.CD003744"},{"key":"BFsrep04076_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1465-9921-8-41","volume":"8","author":"HO Ballard","year":"2007","unstructured":"Ballard, H. O., Anstead, M. I. & Shook, L. A. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. Respir. Res. 8, 41 (2007).","journal-title":"Respir. Res."},{"key":"BFsrep04076_CR33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1177\/0091270010382021","volume":"51","author":"HE Hassan","year":"2011","unstructured":"Hassan, H. E. et al. Pharmacokinetics, safety and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia. J. Clin. Pharmacol. 51, 1264\u201375 (2011).","journal-title":"J. Clin. Pharmacol."},{"key":"BFsrep04076_CR34","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1128\/AAC.02183-12","volume":"57","author":"RM Viscardi","year":"2013","unstructured":"Viscardi, R. M. et al. Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. Antimicrob. Agents Chemother. 57, 2127\u201333 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFsrep04076_CR35","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G. & Stein, C. M. Azithromycin and the risk of cardiovascular death. N. Engl. J. Med. 366, 1881\u20131890 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep04076_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2001-12940","volume":"18","author":"E Bancalari","year":"2001","unstructured":"Bancalari, E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am. J. Perinatol. 18, 1\u20139 (2001).","journal-title":"Am. J. Perinatol."},{"key":"BFsrep04076_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/j.semperi.2007.01.001","volume":"31","author":"RL Schelonka","year":"2007","unstructured":"Schelonka, R. L. & Waites, K. B. Ureaplasma infection and neonatal lung disease. Semin. Perinatol. 31, 2\u20139 (2007).","journal-title":"Semin. Perinatol."},{"key":"BFsrep04076_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00431-011-1565-8","volume":"171","author":"F Kaguelidou","year":"2012","unstructured":"Kaguelidou, F. et al. European survey on the use of prophylactic fluconazole in neonatal intensive care units. Eur. J. Pediatr. 171, 439\u2013445 (2012).","journal-title":"Eur. J. Pediatr."},{"key":"BFsrep04076_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1542\/peds.2004-1697","volume":"114","author":"AR Stark","year":"2004","unstructured":"Stark, A. R. Levels of neonatal care. Pediatrics. 114, 1341\u20131347 (2004).","journal-title":"Pediatrics."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep04076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04076","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T08:19:55Z","timestamp":1672993195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep04076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep04076"],"URL":"https:\/\/doi.org\/10.1038\/srep04076","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,12]]},"assertion":[{"value":"17 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4076"}}